Literature DB >> 8365573

Requirements for promoter activity in mouse oocytes and embryos distinguish paternal pronuclei from maternal and zygotic nuclei.

M Wiekowski1, M Miranda, M L DePamphilis.   

Abstract

Fertilization of mouse eggs produces a 1-cell embryo containing both a paternal and maternal pronucleus. These two nuclei combine during the first mitosis to form the zygotic nuclei of 2-cell embryos. This transition is accompanied by the onset of transcription and the decline of maternal mRNA-dependent gene expression. To determine how changes in nuclear composition affect gene expression, plasmid DNA containing a promoter and an enhancer that function throughout a broad host range was injected into nuclei of oocytes and embryos. The requirements for promoter activity in paternal pronuclei of 1-cell embryos were distinct from those in maternal or zygotic nuclei: (1) Paternal pronuclei permitted high levels of promoter activity relative to maternal or zygotic nuclei. (2) Butyrate, an agent that alters chromatin structure, stimulated promoter activity in maternal or zygotic nuclei, but not in paternal pronuclei. (3) The embryo-responsive polyomavirus F101 enhancer also stimulated promoter activity, but only after formation of a 2-cell embryo. Either butyrate or the F101 enhancer stimulated promoter activity in zygotic nuclei to the level observed in paternal pronuclei. Stimulation also was observed with 2-cell embryos containing nuclei of only maternal or paternal origin, but their transcriptional capacity was more limited. These and other results support the hypothesis that the need for enhancers in 2-cell embryos results from repression by chromatin structure, and the role of enhancers is to relieve this repression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8365573     DOI: 10.1006/dbio.1993.1248

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  32 in total

1.  Reconstitution of enhancer function in paternal pronuclei of one-cell mouse embryos.

Authors:  L Rastelli; K Robinson; Y Xu; S Majumder
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Remodelling the paternal chromatin at fertilization in mammals.

Authors:  David W McLay; Hugh J Clarke
Journal:  Reproduction       Date:  2003-05       Impact factor: 3.906

3.  Epigenetic reprogramming and development: a unique heterochromatin organization in the preimplantation mouse embryo.

Authors:  Adam Burton; Maria-Elena Torres-Padilla
Journal:  Brief Funct Genomics       Date:  2010-12-23       Impact factor: 4.241

Review 4.  Zygotic genome activation during the maternal-to-zygotic transition.

Authors:  Miler T Lee; Ashley R Bonneau; Antonio J Giraldez
Journal:  Annu Rev Cell Dev Biol       Date:  2014-08-11       Impact factor: 13.827

5.  Chromosome methylation patterns during mammalian preimplantation development.

Authors:  N Rougier; D Bourc'his; D M Gomes; A Niveleau; M Plachot; A Pàldi; E Viegas-Péquignot
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

6.  Developmental acquisition of enhancer function requires a unique coactivator activity.

Authors:  S Majumder; Z Zhao; K Kaneko; M L DePamphilis
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

7.  KM mutant highlights enhancers in minor ZGA.

Authors:  Yuki Okada; Keisuke Aoshima
Journal:  Cell Cycle       Date:  2015-06-11       Impact factor: 4.534

Review 8.  Epigenetic modifications and reprogramming in paternal pronucleus: sperm, preimplantation embryo, and beyond.

Authors:  Yuki Okada; Kosuke Yamaguchi
Journal:  Cell Mol Life Sci       Date:  2017-01-03       Impact factor: 9.261

Review 9.  Chromatin-linked determinants of zygotic genome activation.

Authors:  Olga Østrup; Ingrid S Andersen; Philippe Collas
Journal:  Cell Mol Life Sci       Date:  2012-09-11       Impact factor: 9.261

10.  TATA-dependent enhancer stimulation of promoter activity in mice is developmentally acquired.

Authors:  S Majumder; M L DePamphilis
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.